16 November, 2018

Astra Zeneca presents new indications on the benefits of Brilique

Source: AstraZeneca has presented new analyzes of the Pegasus-Timi 54 trial in the framework of the Scientific Conferences of the American Heart Association. These findings […]
15 November, 2018

EMA publishes a report on the impact of Brexit on the authorization of medicines

Source: A day after knowing the draft agreement on Brexit that last Tuesday, November 13, reached the European Union (EU) and the British Government, the […]
8 November, 2018

Europe approves a new indication for Xtandi, from Astellas, for prostate cancer

Source: The European Commission has approved a new indication of enzalutamide, a drug whose trade name is Xtandi and which was registered by the pharmaceutical […]
5 November, 2018

Enhance R & D and protect intellectual property, petitions from the pharmaceutical industry to Europe

Source: In order to highlight the priorities of the sector when there are just over seven months left for the next European elections, a manifesto, […]
30 October, 2018

The AEMPS publishes new features in the treatment of drug registration dossiers

Source: The Spanish Agency for Medicines and Health Products (AEMPS) has published the news regarding the submission of requests for regulatory activities of medicines for […]
25 October, 2018

Cataluña allocates 9.5 million to Peris, its health innovation plan

Source: The government has approved this Tuesday for 9.550.000 euros to attend the 2019 call for grants of the Strategic Plan for Research and Innovation […]
23 October, 2018

New advances in the treatment of head and neck tumors

Source: Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized according to the most recent results of […]
19 October, 2018

Gilead increases its commitment to research in Spain targeting HIV

Source: The biopharmaceutical company Gilead Sciences continues its commitment to research in our country, this time, developing a project to achieve the cure of HIV. […]
18 October, 2018

Breast cancer: the industry leads the research of 169 new drugs

Source: Currently, the pharmaceutical industry has a total of 169 new drugs against breast cancer in the clinical research phase, a disease that encompasses the […]
16 October, 2018

Success of the first trial of Opsumit (Actelion) in portopulmonary hypertension

Source: Actelion Pharmaceuticals has announced the results of the first randomized controlled trial in portopulmonary hypertension (HTPP). This study has shown that Opsumit (macitentan) significantly […]
10 October, 2018

Europe approves Verzenios, from Lilly, for the treatment of advanced breast cancer

Source: The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast […]
8 October, 2018

Genetic mutations also alter the nature of clinical trials

Source: New ways of researching and developing drugs, in their most advanced oncological aspects, urge health administrations, hospitals, patients and their organizations, Research Ethics Committees […]